[1] |
World Health Organization. Global Hepatitis Report, 2017[OR]. WHO 2017: Geneva. http://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/.
|
[2] |
LUXON BA. Bone disorders in chronic liver diseases[J]. Curr Gastroenterol Rep, 2011, 13(1): 40-48. DOI: 10.1007/s11894-010-0166-4.
|
[3] |
QIU ML, XIE Y, WANG XH, et al. Practice guideline for patients with osteoporosis[J]. Chin J Intern Med, 2020, 5(12): 953-959. DOI: 10.3760/cma.j.cn112138-20200904-00792.
邱敏丽, 谢雅, 王晓红, 等. 骨质疏松症患者实践指南[J]. 中华内科学杂志, 2020, 5(12): 953-959. DOI: 10.3760/cma.j.cn112138-20200904-00792.
|
[4] |
Chinese Society of Infectious Diseases, Chinese Medical Association; Chinese Society of Hepatology, Chinese Medical Association. Guidelines for the prevention and treatment of chronic hepatitis B (version 2019)[J]. Chin J Hepatol, 2019, 35(12): 2648-2669. DOI: 10.3969/j.issn.1001-5256.2019.12.007.
中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35(12): 2648-2669. DOI: 10.3969/j.issn.1001-5256.2019.12.007.
|
[5] |
HAYASHI M, ABE K, FUJITA M, et al. Association between sarcopenia and osteoporosis in chronic liver disease[J]. Hepatol Res, 2018, 48(11): 893-904. DOI: 10.1111/hepr.13192.
|
[6] |
SCHREIBER JJ, ANDERSON PA, ROSAS HG, et al. Hounsfield units for assessing bone mineral density and strength: a tool for osteoporosis management[J]. J Bone Joint Surg Am, 2011, 93(11): 1057-1063. DOI: 10.2106/JBJS.J.00160.
|
[7] |
NISHIKAWA H, SHIRAKI M, HIRAMATSU A, et al. Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria[J]. Hepatol Res, 2016, 46(10): 951-963. DOI: 10.1111/hepr.12774.
|
[8] |
WANG YF, SUN MX, XUE H, et al. Understanding the China Blue Paper on Obesity Prevention and Control and policy implications and recommendations for obesity prevention and control in China[J]. Chin J Rrev Med, 2019, 53(9): 875-884. DOI: 10.3760/cma.j.issn.0253-9624.2019.09.003.
王友发, 孙明晓, 薛宏, 等. 《中国肥胖预防和控制蓝皮书》解读及中国肥胖预防控制措施建议[J]. 中华预防医学杂志, 2019, 53(9): 875-884. DOI: 10.3760/cma.j.issn.0253-9624.2019.09.003.
|
[9] |
BYRNE DD, NEWCOMB CW, CARBONARI DM, et al. Risk of hip fracture associated with untreated and treated chronic hepatitis B virus infection[J]. J Hepatol, 2014, 61(2): 210-218. DOI: 10.1016/j.jhep.2014.04.001.
|
[10] |
REID IR. Targeting sclerostin in postmenopausal osteoporosis: Focus on romosozumab and blosozumab[J]. BioDrugs, 2017, 31(4): 289-297. DOI: 10.1007/s40259-017-0229-2.
|
[11] |
FORESTA C, SCHIPILLITI M, CIARLEGLIO FA, et al. Male hypogonadism in cirrhosis and after liver transplantation[J]. J Endocrinol Invest, 2008, 31(5): 470-478. DOI: 10.1007/BF03346393.
|
[12] |
ZHU LJ, KE JT, LI M, et al. Studies related to the clearance of fibroblast growth factor 23 in patients with chronic renal failure by different modes of blood purification[J]. Chin J Integ Trad Western Nephrol, 2014, 15(6): 514-517. https://www.cnki.com.cn/Article/CJFDTOTAL-JXSB201406019.htm
朱丽娟, 柯剑婷, 李宓, 等. 不同血液净化模式对慢性肾衰竭患者成纤维细胞生长因子23清除的相关研究[J]. 中国中西医结合肾病杂志, 2014, 15(6): 514-517. https://www.cnki.com.cn/Article/CJFDTOTAL-JXSB201406019.htm
|
[13] |
ZHANG ZL, WEI Z. Advances in clinical studies of adefovir-induced renal tubular damage and osteochondrosis[J]. Chin J Intern Med, 2018, 57(12): 935-937. DOI: 10.3760/cma.j.issn.0578-1426.2018.12.013.
章振林, 魏哲. 阿德福韦酯引起肾小管损害和骨软化临床研究进展[J]. 中华内科杂志, 2018, 57(12): 935-937. DOI: 10.3760/cma.j.issn.0578-1426.2018.12.013.
|
[14] |
SMITH AD. Screening of bone density at CT: An overlooked opportunity[J]. Radiology, 2019, 291(2): 368-369. DOI: 10.1148/radiol.2019190434.
|
[15] |
BAO J, ZOU D, LI WS. Research progress on lumbar CT attenuation value in assessing bone mineral density of patients with lumbar degenerative diseases[J]. Chin J Spine and Spinal Core, 2020, 30(8): 745-750. DOI: 10.3969/j.issn.1004-406X.2020.08.12.
包洁, 邹达, 李危石. 椎体CT值评估腰椎退变患者骨密度的研究进展[J]. 中国脊柱脊髓杂志, 2020, 30(8): 745-750. DOI: 10.3969/j.issn.1004-406X.2020.08.12.
|
[16] |
LEE S, CHUNG CK, OH SH, et al. Correlation between bone mineral density measured by dual-energy X-Ray absorptiometry and hounsfield units measured by diagnostic CT in lumbar spine[J]. J Korean Neurosurg Soc, 2013, 54(5): 384-389. DOI: 10.3340/jkns.2013.54.5.384.
|
[17] |
HAO RR, WANG H, WANG HY, et al. Analysis of risk factors for senile sarcopenia and its relationship with NAFLD[J]. J Clin Exp Med, 2020, 19(15): 1588-1591. DOI: 10.3969/j.issn.1671-4695.2020.15.006.
郝瑞瑞, 王欢, 王海燕, 等. 老年肌少症的危险因素分析及与NAFLD的关系研究[J]. 临床和实验医学杂志, 2020, 19(15): 1588-1591. DOI: 10.3969/j.issn.1671-4695.2020.15.006.
|
[18] |
CHEN LR, YANG ZY. Research progress of intervention therapy for sarcopenia and understanding of traditional Chinese medicine[J]. Chin J Gerontol, 2021, 41(15): 3389-3392. DOI: 10.3969/j.issn.1005-9202.2021.15.063.
陈丽如, 杨子艳. 肌少症的干预治疗研究进展及中医学认识[J]. 中国老年学杂志, 2021, 41(15): 3389-3392. DOI: 10.3969/j.issn.1005-9202.2021.15.063.
|
[19] |
HOU JC, ZHANG YM. Progress of skeletal muscle mass evaluation, diagnosis and treatment of sarcopenia in patients with liver disease[J]. Chin J Hepatobiliary Surg, 2020, 26(11): 873-877. DOI: 10.3760/cma.j.cn113884-20200304-00112.
侯建存, 张雅敏. 肝病患者肌肉减少症骨骼肌测量及诊治研究进展[J]. 中华肝胆外科杂志, 2020, 26(11): 873-877. DOI: 10.3760/cma.j.cn113884-20200304-00112.
|
[20] |
CAREY EJ, LAI JC, SONNENDAY C, et al. A north american expert opinion statement on sarcopenia in liver transplantation[J]. Hepatology, 2019, 70(5): 1816-1829. DOI: 10.1002/hep.30828.
|
[21] |
GOLSE N, BUCUR PO, CIACIO O, et al. A new definition of sarcopenia in patients with cirrhosis undergoing liver transplantation[J]. Liver Transpl, 2017, 23(2): 143-154. DOI: 10.1002/lt.24671.
|
[22] |
CHEN JC, ZHU GT, LIU HW, et al. Common pathogenesis of "sarco-osteopenia"[J]. Chin J Osteoporosis Bone Miner Res, 2020, 13(1): 95-102. DOI: 10.3969/j.issn.1674-2591.2020.01.015.
陈锦成, 朱国涛, 刘洪文, 等. "肌少-骨质疏松症"的共同发病机制[J]. 中华骨质疏松和骨矿盐疾病杂志, 2020, 13(1): 95-102. DOI: 10.3969/j.issn.1674-2591.2020.01.015.
|
[23] |
FU SW. Clinical study of bone metabolic and biochemical indexes and osteoporosis in patients with liver cirrhosis or liver cancer[J]. Chin J Osteoporos, 2013, 19(11): 1177-1179. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZS201311015.htm
付士武. 肝硬化、肝癌患者骨代谢生化指标与骨质疏松的临床研究[J]. 中国骨质疏松杂志, 2013, 19(11): 1177-1179. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZS201311015.htm
|
[24] |
CHEN CH, LIN CL, KAO CH. Association between chronic hepatitis B virus infection and risk of osteoporosis: A nationwide population-based study[J]. Medicine (Baltimore), 2015, 94(50): e2276. DOI: 10.1097/MD.0000000000002276.
|